Dr. Carol Kasper: Honoring the Legacy
Brian O Mahony, CEO of Irish Haemophilia Society,former President of WFH and EHC, shared a devastating news on X:
”I was immensely sad today to hear of the passing of Dr. Carol Kasper, a pioneering treater of haemophilia, a great researcher, a wonderful writer (her Hemophilia Bulletin in the 1990s and early 2000s was the best source of information). I had the great pleasure of working closely with Carol from 1994 to 2002 when she was Vice President Medical of The World Federation of Hemophilia and I was President. She was immensely knowledgable, a great teacher and very empatetic. She was great fun to travel with and had a great sense of humour. She added value to many lives.”
We are deeply saddened by the passing of Dr. Carol Kasper, a pioneering figure in hemophilia care and a beloved member of the global bleeding disorders community.
Dr. Kasper was not only a brilliant clinician and researcher but also a gifted communicator—her Hemophilia Bulletin in the 1990s and early 2000s remains one of the most insightful resources of its time.
Her legacy will live on!
Stay updated on the news in hematology field with Hemostasis Today.
-
Jan 14, 2026, 11:38Khokon Miah Akanda Shares A major 4-Guideline Comparison on BP Management in Stroke
-
Jan 14, 2026, 11:26Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
-
Jan 14, 2026, 11:16ISTH 2026: Laurent Bertoletti To Serve as Vice Theme Leader for VTE
-
Jan 14, 2026, 11:08Leni von Bonsdorff Invites You to Hear and Learn The Latest News in The Plasma Field
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription